• VX-702: Redefining Precision in p38α MAPK Inhibition for Tra

  2026-08-04

  This thought-leadership article explores how VX-702, a next-generation p38α MAPK inhibitor, is advancing the field of inflammation and autoimmune disease research. By synthesizing mechanistic breakthroughs in kinase and phosphatase interplay, the article offers strategic guidance for translational researchers seeking to optimize experimental design, interpret functional outcomes, and chart the future of dual-action inhibitor development. It uniquely bridges structural biochemistry with real-world translational workflows, moving beyond conventional product summaries to deliver actionable insight.

• Baicalin Restores Visual Cortex Plasticity in Adult Amblyopi

  2026-08-04

  This study demonstrates that baicalin, a flavone glycoside from Scutellaria baicalensis, can reactivate ocular dominance plasticity and restore visual acuity in adult mice with amblyopia. The work provides mechanistic insight into GABAergic inhibition modulation and positions baicalin as a promising agent for adult visual system repair.

• Steroid-Induced Protoplast Lysis: Mechanisms and Antagonists

  2026-08-03

  Smith and Shay's 1965 study pioneered the use of bacterial protoplasts to dissect the mechanism of action of synthetic antimicrobial steroids, demonstrating that their lytic effects target cell membranes rather than cell walls. Their rigorous comparisons with stabilizers and antagonists established foundational insights into membrane vulnerability, informing modern antimicrobial and cell-based assay design.

• MAPK10 Phosphorylation of KRT16 Suppresses NSCLC Metastasis

  2026-08-03

  This study identifies MAPK10 as a key suppressor of non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination and degradation of keratin 16. The findings reveal a novel MAPK10/KRT16/RNF213 axis as a promising therapeutic and prognostic target, refining our understanding of metastatic regulation in NSCLC.

• Distinct ERK5 and ERK1/2 Roles in Vitamin D3-Induced AML Dif

  2026-08-02

  This study demonstrates that ERK5 and ERK1/2 MAPK pathways have functionally distinct roles in terminal differentiation of myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. The findings reveal that ERK5 inhibition alters lineage marker expression and cell cycle progression, while ERK1/2 blockade broadly suppresses differentiation—informing more precise strategies for cancer therapy.

• PreScission Protease (PSP): Protocols for Tag Cleavage

  2026-08-01

  PreScission Protease (PSP) enables precise removal of fusion protein tags in purification workflows, especially when low-temperature, site-specific cleavage is required. It is not suitable for non-cognate cleavage sequences or applications outside molecular biology, and requires careful buffer and storage management to maintain optimal activity.

• Vacuolin-1 and the Precision Inhibition of Lysosomal Exocyto

  2026-07-31

  Explore how Vacuolin-1, a potent lysosomal exocytosis inhibitor, is transforming membrane trafficking research. This article offers advanced mechanistic insights and practical considerations for assay design, providing a uniquely integrated perspective beyond standard protocol discussions.

• 3X (DYKDDDDK) Peptide: Reliable Epitope Tag for Robust Assay

  2026-07-31

  This article addresses persistent laboratory challenges in protein detection and purification, demonstrating how the 3X (DYKDDDDK) Peptide (SKU A6001) offers reproducible, high-sensitivity solutions. Drawing on scenario-driven Q&A, it details best practices, protocol parameters, and evidence-based vendor selection for researchers seeking reliability in affinity purification and immunodetection workflows.

• Repurposing Lopinavir: Inhibition of MERS-CoV in Cell Cultur

  2026-07-30

  de Wilde et al. identified Lopinavir (ABT-378) as one of four FDA-approved small molecules capable of inhibiting MERS-CoV replication at low-micromolar concentrations in cell culture. Their study demonstrates the value of drug repurposing for emerging coronavirus threats and provides a foundation for further antiviral research.

• Wnt-C59: Precision PORCN Inhibition in Wnt Signaling and Can

  2026-07-30

  Discover how Wnt-C59, a potent PORCN inhibitor, enables precise dissection of Wnt secretion and signaling in cancer research. This article uniquely contrasts Wnt-C59's mechanistic impact with lithium-driven Wnt/β-catenin activation, offering advanced guidance for experimental design.

• 4-Hydroxytamoxifen: Protocol Parameters and Workflow Best Pr

  2026-07-29

  4-Hydroxytamoxifen is a high-purity estrogen receptor modulator suited for DMSO-based protocols in breast cancer, prostate cancer, and cardiac myocyte calcium handling studies. It should not be used in workflows requiring ethanol or aqueous solubility, and strict storage and handling are necessary for reproducible results.

• Hexa His Tag Peptide: Mechanistic Insights for Precision Pro

  2026-07-29

  Discover how Hexa His tag peptide streamlines 6X His-tagged protein purification, with a focus on mechanistic detail and assay optimization. This article offers unique, evidence-based guidance for advanced molecular workflows.

• c-Myc tag Peptide: Mechanistic Precision in Translational Re

  2026-07-28

  Explore how the c-Myc tag Peptide advances immunoassay innovation and mechanistic insight into transcription factor regulation, bridging competitive displacement strategies with new paradigms in oncology and immunology. This article provides translational researchers with actionable guidance, integrating recent advances in selective autophagy and transcription factor stability for more robust and insightful experimental workflows.

• Amikacin (BAY416651): Mechanisms and Precision Use in Resist

  2026-07-28

  Explore how Amikacin (BAY416651), a semi-synthetic aminoglycoside, enables advanced research into antibiotic resistance—especially in multidrug-resistant Enterobacter cloacae. Discover new insights on resistance gene dynamics and practical assay strategies.

• Imatinib Hydrochloride in Cancer Research: Enhanced Protocol

  2026-07-27

  Imatinib hydrochloride (STI571 hydrochloride) is a benchmark tyrosine kinase inhibitor, enabling precise interrogation of oncogenic signaling in both in vitro and in vivo models. This guide delivers actionable workflows, novel mechanistic insights, and troubleshooting strategies for maximizing reproducibility and data quality in cancer research using APExBIO's Imatinib hydrochloride.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page